LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it received FDA 510(k) clearance for the U.S. market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results